Page 63 - GPD-2-2
P. 63

Gene & Protein in Disease                                                Transfection methods for TK6 cells



            5.   Praveen  BB,  Stevenson  DJ, Antkowiak  M,  et al.,  2011,   16.  Mehier-Humbert S, Guy RH, 2005, Physical methods for
               Enhancement and optimization of plasmid expression   gene transfer: Improving the kinetics of gene delivery into
               in femtosecond optical transfection.  J  Biophotonics,   cells. Adv Drug Deliv Rev, 57(5): 733–753.
               4(4): 229–235.
                                                                  https://doi.org/10.1016/j.addr.2004.12.007
               https://doi.org/10.1002/jbio.201000105          17.  Schenborn ET, Goiffon V, 2000, DEAE-dextran transfection
            6.   Cerda MB, Batalla M, Anton M, et al., 2015, Enhancement of   of mammalian cultured cells.  Methods Mol Biol,
               nucleic acid delivery to hard-to-transfect human colorectal   130: 147–153.
               cancer cells by magnetofection at laminin coated substrates      https://doi.org/10.1385/1-59259-686-x:147
               and promotion of the endosomal/lysosomal escape.  RSC
               Adv, 5(72): 58345–58454.                        18.  Smolders S, Kessels S, Smolders SM,  et al., 2018,
                                                                  Magnetofection is superior to other chemical transfection
            7.   Keller AA, Scheiding B, Breitling R, et al., 2019, Transduction   methods  in  a microglial  cell line.  J  Neurosci  Method,
               and transfection of difficult‐to‐transfect cells: Systematic   293: 169–173.
               attempts for the transfection of protozoa Leishmania. J Cell
               Biochem, 120(1): 14–27.                            https://doi.org/10.1016/j.jneumeth.2017.09.017
               https://doi.org/10.1002/jcb.27463               19.  Park JS, Surendran S, Kamendulis LM,  et al., 2011,
                                                                  Comparative nucleic acid transfection efficacy in primary
            8.   Ensenauer R, Hartl D, Vockley J,  et al., 2011, Efficient   hepatocytes for gene silencing and functional studies. BMC
               and gentle siRNA delivery by magnetofection.  Biotech   Res Notes, 4(1): 8.
               Histochem, 86(4): 226–231.
                                                                  https://doi.org/10.1186/1756-0500-4-8
               https://doi.org/10.3109/10520291003675485
                                                               20.  Alatorre-Meda M, González-Pérez A, Rodríguez JR, 2010,
            9.   Kroeger K, Collins M, Ugozzoli L, 2009, The preparation   DNA-METAFECTENE  PRO complexation: A  physical
                                                                                   ™
               of primary hematopoietic cell cultures from murine bone   chemistry study. Phys Chem Chem Phys, 12(27): 7464–7472.
               marrow for electroporation. J Vis Exp, 6(23): 1026.
                                                                  https://doi.org/10.1039/B920900J
               https://doi.org/10.3791/1026
                                                               21.  Maucksch C, Aneja MK, Hennen E, et al., 2008, Cell type
            10.  McCoy AM, Collins ML, Ugozzoli LA, 2010, Using the gene   differences in activity of the Streptomyces bacteriophage
               pulser MXcell electroporation system to transfect primary   phiC31 integrase. Nucleic Acids Res, 36(17): 5462–5471.
               cells with high efficiency. J Vis Exp, 35: 1662.
                                                                  https://doi.org/10.1093/nar/gkn532
               https://doi.org/10.3791/1662
                                                               22.  Riccetti L, Sperduti S, Lazzaretti C, et al., 2019, Glycosylation
            11.  Sridharan A, Patel C, Muthuswamy J, 2013, Voltage   pattern and in vitro bioactivity of reference follitropin alfa
               preconditioning  allows  modulated  gene  expression  in   and biosimilars. Front Endocrinol (Lausanne), 10: 503.
               neurons using PEI-complexed siRNA.  Mol Ther Nucleic
               Acids, 2: e82.                                     https://doi.org/10.3389/fendo.2019.00503
               https://doi.org/10.1038/mtna.2013.10            23.  Hoser SM, Hoffmann A, Meindl A,  et al., 2020, Intronic
                                                                  tRNAs of mitochondrial origin regulate constitutive and
            12.  Nyamay’Antu A, Dumont M, Kedinger V, et al., 2019, Non-  alternative splicing. Genome Biol, 21(1): 299.
               viral vector mediated gene delivery: The outsider to watch
               out for in gene therapy. Cell Gene Ther Insights, 5: 51–57.     https://doi.org/10.1186/s13059-020-02199-6
               https://doi.org/10.18609/cgti.2019.007          24.  Kataoka H, Saeki A, Hasebe A,  et al., 2021, Naringenin
                                                                  suppresses Toll‐like receptor 2‐mediated inflammatory
            13.  Thomas CE, Ehrhardt A, Kay MA, 2003, Progress and   responses through inhibition of receptor clustering on lipid
               problems with the use of viral vectors for gene therapy. Nat   rafts. Food Sci Nutr, 9(2): 963–972.
               Rev Genet, 4(5): 346–358.
                                                                  https://doi.org/10.1002/fsn3.2063
               https://doi.org/10.1038/nrg1066
                                                               25.  Kim DY, Park JS, Leem YH, et al., 2021, The potent PDE10A
            14.  Karra D, Dahm R, 2010, Transfection techniques for   inhibitor  MP-10 (PF-2545920)  suppresses  microglial
               neuronal cells. J Neurosci, 30(18): 6171–6177.     activation in LPS-induced neuroinflammation and MPTP-
               https://doi.org/10.1523/JNEUROSCI.0183-10.2010     induced parkinson’s disease mouse models. J Neuroimmune
                                                                  Pharmacol, 16(2): 470–482.
            15.  Thumann G, Stöcker M, Maltusch C,  et al., 2010, High
               efficiency non-viral transfection of retinal and iris pigment      https://doi.org/10.1007/s11481-020-09943-6
               epithelial cells with pigment epithelium-derived factor. Gene   26.  Vozza-Brown L, Fan J, Vasu S, et al., 2015, Lipofectamine
                                                                                                            ™
               Ther, 17(2): 181–189.
                                                                  LTX: A New Transfection Reagent for Effective Transfection
               https://doi.org/10.1038/gt.2009.124                of  Primary  Cells,  Hard-To-Transfect Cells  and  Sensitive

            Volume 2 Issue 2 (2023)                         10                       https://doi.org/10.36922/gpd.0353
   58   59   60   61   62   63   64   65   66   67   68